The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Children and Adolescents

Julie Magno Zito, Daniel J. Safer

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationPharmacovigilance
Subtitle of host publicationSecond Edition
PublisherJohn Wiley & Sons, Ltd
Pages559-570
Number of pages12
ISBN (Print)0470018038, 9780470018033
DOIs
StatePublished - Feb 7 2007

Keywords

  • Antidepressants (ATDs) and selective serotonin reuptake inhibitor (SSRI)
  • FDA clinical trial analysis (DNDP)
  • Risk assessment of selective serotonin reuptake inhibitors (SSRIs)
  • SSRIs and major depressive disorder (MDD)
  • South Carolina Medicaid youth population ATD assessment

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this